Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Aushev VN"'
Autor:
Vasily N. Aushev, Fiorella Belpoggi, Gail C. Garbowski, Fabiana Manservisi, Humberto Parada, Jia Chen, Regina M. Santella, Hanina Hibshoosh, Simona Panzacchi, Susan L. Teitelbaum, Marilie D. Gammon, Laura Falcioni, Kalpana Gopalakrishnan
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Phthalates are commonly included as ingredients in personal care products such as cosmetics, shampoos and perfumes. Diethyl phthalate (DEP) has been found to be anti-androgenic and linked with adverse reproductive effects on males, but effects on fem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1292c838d469c90cd4f8a9d3bc860071
http://hdl.handle.net/11585/775106
http://hdl.handle.net/11585/775106
Autor:
Nakamura Y; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan.; International Research Promotion Office, National Cancer Center Hospital East, Kashiwa, Japan., Watanabe J; Department of Colorectal Surgery, Kansai Medical University, Hirakata, Japan.; Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan., Akazawa N; Department of Gastroenterological Surgery, Sendai City Medical Center Sendai Open Hospital, Sendai, Japan., Hirata K; Department of Surgery 1, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Kataoka K; Division of Lower GI, Department of Gastroenterological Surgery, Hyogo Medical University, Kobe, Japan., Yokota M; Department of General Surgery, Kurashiki Central Hospital, Kurashiki, Japan., Kato K; Department of Surgery, Teine-Keijinkai Hospital, Sapporo, Japan., Kotaka M; Gastrointestinal Cancer Center, Sano Hospital, Kobe, Japan., Kagawa Y; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.; Department of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Japan., Yeh KH; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Mishima S; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Yukami H; Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, Takatsuki, Japan., Ando K; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Miyo M; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan., Misumi T; Department of Data Science, National Cancer Center Hospital East, Kashiwa, Japan., Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Sunto-gun, Japan., Ebi H; Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, Nagoya, Japan., Okita K; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan., Hamabe A; Department of Gastroenterological Surgery, Osaka University, Osaka, Japan., Sokuoka H; Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan., Kobayashi S; EPS Corporation, Tokyo, Japan., Laliotis G; Natera, Inc., Austin, TX, USA., Aushev VN; Natera, Inc., Austin, TX, USA., Sharma S; Natera, Inc., Austin, TX, USA., Jurdi A; Natera, Inc., Austin, TX, USA., Liu MC; Natera, Inc., Austin, TX, USA., Aleshin A; Natera, Inc., Austin, TX, USA., Rabinowitz M; Natera, Inc., Austin, TX, USA., Bando H; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Translational Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan., Taniguchi H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan., Takemasa I; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Sapporo, Japan., Kato T; Department of Surgery, NHO Osaka National Hospital, Osaka, Japan., Kotani D; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Mori M; Tokai University School of Medicine, Isehara, Japan., Yoshino T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. tyoshino@east.ncc.go.jp.; Kindai University Faculty of Medicine, Osaka-Sayama, Japan. tyoshino@east.ncc.go.jp., Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. oki.eiji.857@m.kyushu-u.ac.jp.
Publikováno v:
Nature medicine [Nat Med] 2024 Nov; Vol. 30 (11), pp. 3272-3283. Date of Electronic Publication: 2024 Sep 16.
Autor:
Kalashnikova E; Natera, Inc., Austin, TX, USA., Aushev VN; Natera, Inc., Austin, TX, USA., Malashevich AK; Natera, Inc., Austin, TX, USA., Tin A; Natera, Inc., Austin, TX, USA., Krinshpun S; Natera, Inc., Austin, TX, USA., Salari R; Natera, Inc., Austin, TX, USA., Scalise CB; Natera, Inc., Austin, TX, USA., Ram R; Natera, Inc., Austin, TX, USA., Malhotra M; Natera, Inc., Austin, TX, USA., Ravi H; Natera, Inc., Austin, TX, USA., Sethi H; Natera, Inc., Austin, TX, USA., Sanchez S; Natera, Inc., Austin, TX, USA., Hagelstrom RT; Natera, Inc., Austin, TX, USA., Brevnov M; Natera, Inc., Austin, TX, USA., Rabinowitz M; Natera, Inc., Austin, TX, USA., Moshkevich S; Natera, Inc., Austin, TX, USA., Zimmermann BG; Natera, Inc., Austin, TX, USA., Liu MC; Natera, Inc., Austin, TX, USA., Aleshin A; Natera, Inc., Austin, TX, USA.
Publikováno v:
Molecular oncology [Mol Oncol] 2024 Nov; Vol. 18 (11), pp. 2649-2657. Date of Electronic Publication: 2023 Dec 23.
Autor:
Botta GP; Division of Hematology and Oncology, Department of Medicine, University of California San Diego Moores Cancer Center, La Jolla, CA 92037, United States., Abdelrahim M; Section of GI Oncology, Department of Medical Oncology, Houston Methodist Cancer Center, Houston, TX 77030, United States., Drengler RL; Medical Oncology, The START Center for Cancer Care, San Antonio, TX 78229, United States., Aushev VN; Oncology, Natera, Inc., Austin, TX 78753, United States., Esmail A; Section of GI Oncology, Department of Medical Oncology, Houston Methodist Cancer Center, Houston, TX 77030, United States., Laliotis G; Oncology, Natera, Inc., Austin, TX 78753, United States., Brewer CM; Oncology, Natera, Inc., Austin, TX 78753, United States., George GV; Oncology, Natera, Inc., Austin, TX 78753, United States., Abbate SM; Medical Oncology, The START Center for Cancer Care, San Antonio, TX 78229, United States., Chandana SR; Department of Gastrointestinal Medical Oncology, Cancer & Hematology Centers of Western Michigan, Grand Rapids, MI 49546, United States., Tejani MA; Hematology and Oncology, Advent Health Cancer Institute, Orlando, FL 32804, United States., Malla M; Section of Hematology and Oncology, University of Alabama at Birmingham, AL 35233,United States., Bansal D; Department of Hematology-Oncology, Saint Luke's Cancer Institute, Kansas City, MO 64111, United States., Rivero-Hinojosa S; Oncology, Natera, Inc., Austin, TX 78753, United States., Spickard E; Oncology, Natera, Inc., Austin, TX 78753, United States., McCormick N; Oncology, Natera, Inc., Austin, TX 78753, United States., Cecchini M; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT 06520, United States., Lacy J; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT 06520, United States., Fei N; Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, United States., Kasi PM; Division of Internal Medicine, Department of Oncology/Hematology, Weill Cornell Medicine, New York, NY 10021, United States., Kasi A; Division of Medical Oncology, Department of Medicine, Kansas University Cancer Center, Kansas City, KS 66160, United States., Dayyani F; Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA 92868, United States., Hanna DL; Division of Medical Oncology, Norris Cancer Center, Keck Medicine of USC, Los Angeles, CA 90033, United States., Sharma S; Oncology, Natera, Inc., Austin, TX 78753, United States., Malhotra M; Oncology, Natera, Inc., Austin, TX 78753, United States., Aleshin A; Oncology, Natera, Inc., Austin, TX 78753, United States., Liu MC; Oncology, Natera, Inc., Austin, TX 78753, United States., Jurdi A; Oncology, Natera, Inc., Austin, TX 78753, United States.
Publikováno v:
The oncologist [Oncologist] 2024 Oct 03; Vol. 29 (10), pp. 859-869.
Autor:
Camonis JH; Institut Curie, Inserm U830, Stress and Cancer Laboratory, PSL Research University, 26 rue d'Ulm, 75005, Paris, France. jacquescamonis@gmail.com.; IHPST_UMR-CNRS8590, 13 rue Dufour, 75006, Paris, France. jacquescamonis@gmail.com., Aushev VN; Natera Inc, San Carlos, CA, 94070, USA., Zueva E; Institut Curie, Inserm U932, Université PSL, 75005, Paris, France., Zalcman G; Université Paris Cité, Thoracic Oncology Department, Hôpital Bichat, AP-HP.Nord & U830 Inserm Stress and Cancer Laboratory, Institut Curie, 26 rue d'Ulm, 75005, Paris, France.
Publikováno v:
Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 Oct 01; Vol. 81 (1), pp. 412. Date of Electronic Publication: 2024 Oct 01.
Autor:
Cecchini M; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Salem RR; Department of Surgery, Yale University School of Medicine, New Haven, Connecticut., Robert M; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut., Czerniak S; Department of Radiology, Yale University School of Medicine, New Haven, Connecticut., Blaha O; Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut., Zelterman D; Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut., Rajaei M; Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut., Townsend JP; Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut., Cai G; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut., Chowdhury S; Department of Therapeutic Radiology, Yale School of Public Health, New Haven, Connecticut., Yugawa D; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.; Department of Therapeutic Radiology, Yale School of Public Health, New Haven, Connecticut., Tseng R; Department of Therapeutic Radiology, Yale School of Public Health, New Haven, Connecticut., Mejia Arbelaez C; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.; Department of Therapeutic Radiology, Yale School of Public Health, New Haven, Connecticut., Jiao J; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut., Shroyer K; Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York., Thumar J; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Kortmansky J; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Zaheer W; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Fischbach N; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Persico J; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Stein S; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Khan SA; Department of Surgery, Yale University School of Medicine, New Haven, Connecticut., Cha C; Department of Surgery, Yale University School of Medicine, New Haven, Connecticut., Billingsley KG; Department of Surgery, Yale University School of Medicine, New Haven, Connecticut., Kunstman JW; Department of Surgery, Yale University School of Medicine, New Haven, Connecticut., Johung KL; Department of Therapeutic Radiology, Yale School of Public Health, New Haven, Connecticut., Wiess C; Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Muzumdar MD; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Spickard E; Natera Inc, Austin, Texas., Aushev VN; Natera Inc, Austin, Texas., Laliotis G; Natera Inc, Austin, Texas., Jurdi A; Natera Inc, Austin, Texas., Liu MC; Natera Inc, Austin, Texas., Escobar-Hoyos L; Department of Therapeutic Radiology, Yale School of Public Health, New Haven, Connecticut.; Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut., Lacy J; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Aug 01; Vol. 10 (8), pp. 1027-1035.
Autor:
Maddalena G; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Oncology Unit 1, Veneto Institute of Oncology-IRCCS, Padova; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy., Zeineddine FA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Rivero-Hinojosa S; Natera, Inc., Austin., Aushev VN; Natera, Inc., Austin., Chowdhury S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Zeineddine MA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Yousef AM; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Yap TA; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston; Khalifa Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston; The Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston., EINaggar AC; Natera, Inc., Austin., Liu MC; Natera, Inc., Austin., White M; Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA., Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Shen JP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: jshen8@mdanderson.org.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jul; Vol. 35 (7), pp. 678-680. Date of Electronic Publication: 2024 May 09.
Autor:
Eckhoff AM; Department of Surgery, Duke University, Durham, NC, USA., Kanu E; Department of Surgery, Duke University, Durham, NC, USA., Fletcher A; Department of Surgery, Duke University, Durham, NC, USA., Bao M; Department of Surgery, Duke University, Durham, NC, USA., Aushev VN; Natera, Austin, TX, USA., Spickard E; Natera, Austin, TX, USA., Nussbaum DP; Department of Surgery, Duke University, Durham, NC, USA., Allen PJ; Department of Surgery, Duke University, Durham, NC, USA. peter.allen@duke.edu.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2024 Mar; Vol. 31 (3), pp. 1444-1446. Date of Electronic Publication: 2024 Jan 03.
Autor:
Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London ECMC, Barts Health, London, United Kingdom., Young A; Foundation Medicine, Cambridge, MA, United States., Nimeiri H; Foundation Medicine, Cambridge, MA, United States., Madison RW; Foundation Medicine, Cambridge, MA, United States., Fine A; Foundation Medicine, Cambridge, MA, United States., Zollinger DR; Foundation Medicine, Cambridge, MA, United States., Huang Y; Foundation Medicine, Cambridge, MA, United States., Xu C; Foundation Medicine, Cambridge, MA, United States., Gjoerup OV; Foundation Medicine, Cambridge, MA, United States., Aushev VN; Natera, Austin, TX, United States., Wu HT; Natera, Austin, TX, United States., Aleshin A; Natera, Austin, TX, United States., Carter C; Roche/Genentech, South San Francisco, CA, United States., Davarpanah N; Roche/Genentech, South San Francisco, CA, United States., Degaonkar V; Roche/Genentech, South San Francisco, CA, United States., Gupta P; Roche/Genentech, South San Francisco, CA, United States., Mariathasan S; Roche/Genentech, South San Francisco, CA, United States., Schleifman E; Roche/Genentech, South San Francisco, CA, United States., Assaf ZJ; Roche/Genentech, South San Francisco, CA, United States., Oxnard G; Foundation Medicine, Cambridge, MA, United States., Hegde PS; Foundation Medicine, Cambridge, MA, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Jul 31; Vol. 13, pp. 1221718. Date of Electronic Publication: 2023 Jul 31 (Print Publication: 2023).
Autor:
Azzi G; HolyCross Medical Group, Ft. Lauderdale, FL, USA., Tavallai M; Natera, Inc., Austin, TX, USA., Aushev VN; Natera, Inc., Austin, TX, USA., Koyen Malashevich A; Natera, Inc., Austin, TX, USA., Botta GP; UC San Diego Health, San Diego, CA, USA., Tejani MA; AdventHealth Cancer Institute, Orlando, FL, USA., Hanna D; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Krinshpun S; Natera, Inc., Austin, TX, USA., Malhotra M; Natera, Inc., Austin, TX, USA., Jurdi A; Natera, Inc., Austin, TX, USA., Aleshin A; Natera, Inc., Austin, TX, USA., Kasi PM; Weill Cornell Medicine, New York, NY, USA.
Publikováno v:
The oncologist [Oncologist] 2023 Mar 17; Vol. 28 (3), pp. 220-229.